15%
Extra Off On Every Report
Viral Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast To 2025
Report ID
Category
Pages
Report Status
10% Free Customization

Description

Vaccines are biotic compositions. They are basically formulated from living beings that increase the resistance against a specific illness. Vaccinations that help in avoiding the occurrence of specific diseases are known as prophylactic vaccines and in other instance, the vaccines that are helpful in treating the disease are called therapeutic vaccines. A vaccine is generally produced by using a weakened or murdered type of the sickness causing microorganism. The agent penetrates the immune system of body to perceive the agent as a risk, crush it, and to moreover identify and annihilate any of the microorganisms related with that particular operator that it might affect in near future. Vaccinations plays vital role in maintaining the supportable people’s health across the globe; therefore, they are used to prevent various regional disease. Due to the rise in cases of both viral and bacterial contagious diseases the demand for vaccinations has increased over the last few years. Vaccines are basically regulated to the different people of different age groups. Vaccinations supports their immune system throughout their life and provides safety against distinct types of infectious diseases.

However, shipping of vaccines and cost related with storage and restricted compensation coverage are forecasted to confine the global viral vaccines market during the forecast period. Furthermore, rigorous governmental rules for the support of biotic products is likely to hinder the growth of the global viral vaccine market in the upcoming years. The world-wide viral vaccines market is determined by the increase in frequency of infective diseases, as they are considered to be the finest way to avoid such diseases. The influence of the dynamic factors is moreover to surpass the restraints. Furthermore, development of new markets and rise in adoption of combination of vaccines in preventing strategies by government are responsible for the new and growing opportunities in the future.

Majorly, there are four types of primary vaccines. Which are live inactivated vaccines, attenuated vaccines, toxoid vaccines and conjugate vaccines. Viral vaccines are consists of killed or attenuated virus or their product that can trigger the immune system to produce antibodies in contradiction of them. Depending upon the indications, the vaccines can be further divided into pneumococcal disease; influenza; human papilloma virus; rotavirus;  meningococcal disease; varicella; diphtheria, measles, and tetanus (DTP), polio; hepatitis; pertussis, mumps, and rubella (MMR); and other indications. Considering the end use, it is categorized into adult vaccines, pediatric vaccines and traveler vaccines. Further, viral vaccine can be segmented into technology, indication, end use and region.

The major players dominating the global viral vaccine market are PaxVax Corporation., Gritstone Oncology, Bharat Biotech, Novavax, Inc., VBI Vaccines Inc., Dynavax Technologies Corporation, Bavarian Nordic, Biology Ltd.  Gamma Vaccines Pty Limited, Prokarium, Sinovac Biotech Ltd., Immunomic Therapeutics, Inc,

Table of Content

 

  1. EXECUTIVE SUMMARY
  2. RESEARCH METHODOLOGY
    1. Market Definition
    2. Market Scope
    3. Data Sources
  3. MARKET DYNAMICS
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. INDUSTRY OVERVIEW
    1. Value Chain Analysis
    2. Porter’s Five Forces Analysis
    3. Key Trends
  5. GLOBAL VIRAL VACCINE BY TYPE (2017-2023)
    1. Global Viral Vaccine by inactivated vaccines
    2. Global Viral Vaccine by conjugate vaccines
    3. Global Viral Vaccine by toxoid vaccines
    4. Global Viral Vaccine by attenuated vaccines
  6. GLOBAL VIRAL VACCINE BY INDICATIONS (2017-2023)
    1. Global Viral Vaccine by pneumococcal disease
    2. Global Viral Vaccine by Human Papilloma Virus
    3. Global Viral Vaccine by Rotavirus
    4. Global Viral Vaccine by Varicella
    5. Global Viral Vaccine by Diphtheria
    6. Global Viral Vaccine by Polio
    7. Global Viral Vaccine by Meningococcal Disease
    8. Global Viral Vaccine by Measles, Mumps, and Rubella (MMR)
  7. GLOBAL VIRAL VACCINE, BY REGIONS (2017-2023)
    1. North America Viral Vaccine
      1. North America Viral Vaccine by Type
      2. North America Viral Vaccine by Application Type
      3. North America Viral Vaccine by Country
        1. U.S. Viral Vaccine
        2. Rest of North America Viral Vaccine
    2. Europe Viral Vaccine
      1. Europe Viral Vaccine by Market Type
      2. Europe Viral Vaccine by Application Type
      3. Europe Viral Vaccine by Country
        1. France Viral Vaccine
        2. Germany Viral Vaccine
        3. U.K Viral Vaccine
        4. Rest of Europe Viral Vaccine
    3. Asia Pacific Viral Vaccine
      1. Asia-Pacific Viral Vaccine by Market Type
      2. Asia-Pacific Viral Vaccine by Application Type
      3. Asia-Pacific Viral Vaccine by Country
        1. China Viral Vaccine
        2. Japan Viral Vaccine
        3. India Viral Vaccine
        4. Rest of Asia Pacific Viral Vaccine
    4. Middle East & Africa Viral Vaccine
      1. Middle East & Africa Viral Vaccine by Type
      2. Middle East & Africa Viral Vaccine by Application Type
      3. Middle East & Africa Viral Vaccine by Country
        1. GCC Viral Vaccine
        2. North Africa Viral Vaccine
        3. South Africa Viral Vaccine
        4. Rest of Middle East & Africa Viral Vaccine
    5. Latin America Viral Vaccine
      1. Latin America Viral Vaccine by Type
      2. Latin America Viral Vaccine by Application Type
      3. Latin America Viral Vaccine by Country
        1. Brazil Viral Vaccine
        2. Rest of Latin America Viral Vaccine
  8. MARKET COMPETITION ANALYSIS
    1. Market Share/Positioning Analysis
    2. Key Innovators
    3. Company Profiles
      1. PaxVax Corporation
        1. Overview
        2. Type/Service Offerings
        3. Strategy
        4. Key Developments
      2. BASF SE.
        1. Overview
        2. Type/Service Offerings
        3. Strategy
        4. Key Developments
      3. Novavax, Inc.
        1. Overview
        2. Type/Service Offerings
        3. Strategy
        4. Key Developments
      4. Biology Ltd.
        1. Overview
        2. Type/Service Offerings
        3. Strategy
        4. Key Developments
      5. Immunomic Therapeutics
        1. Overview
        2. Type/Service Offerings
        3. Strategy
        4. Key Developments
      6. Sinovac Biotech Ltd.,
        1. Overview
        2. Type/Service Offerings
        3. Strategy
        4. Key Developments
      7. Prokarium
        1. Overview
        2. Type/Service Offerings
        3. Strategy
        4. Key Developments
      8. ImmunoBiology Ltd.
        1. Overview
        2. Type/Service Offerings
        3. Strategy
        4. Key Developments
      9. Sinovac Biotech Ltd
        1. Overview
        2. Type/Service Offerings
        3. Strategy
        4. Key Developments
      10. VBI Vaccines Inc..
        1. Overview
        2. Type/Service Offerings
        3. Strategy
        4. Key Developments

Research Methodology

This research study involved the usage of extensive secondary sources; directories; databases such as Hoovers, Bloomberg Business, Factiva, and Avention; white papers; annual reports; company house documents; and SEC filings of companies. Secondary research was mainly used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the market. It was also used to obtain key information about the market classification and segmentation according to the industry trends, regional markets, and developments related to the market and technology perspectives. Primary sources were mainly several industry experts from core and related industries; and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry‘s value chain. In-depth interviews were conducted from various primary respondents which included key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information as well as to assess future prospects. The following figure shows the market research methodology applied in making this report.



After the complete market engineering (which includes calculations for market statistics, market breakdown, market size estimation, market forecasting, and data triangulation), extensive primary research was conducted to gather information and to verify and validate the critical numbers arrived at. Primary research was also conducted to identify the segmentation types and key market dynamics such as drivers, restraints, and opportunities.

In the complete market engineering process, both top-down and bottom-up approaches were extensively used along with several data triangulation methods to perform market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list key information/insights throughout the report.

License Type

Single User(PDF)    :   $ 4699
Multiple User(PDF)    :   $ 6699
Enterprise(PDF)    :   $ 8999

Please choose the suitable license type from above.



CUSTOM RESEARCH

We Can Customize The Report According To Your Need If Listed Report Does Not Meet Your Requirements,Our Research Will Cover All The Businesses Information Required By You.
Please Fill In The Customization Form With Your Requirements.

Help

Email Address:
[email protected]

Toll Free:
+1- 844-445-2861

More FAQ

© Copyright 2017-18 All rights reserved.